Cytofluorometric methods for assessing absolute numbers of cell subsets in blood

Communications in Clinical Cytometry

Volumn 42, Issue 6, 2000, Pages 327-346

  Brando, Bruno ^a   Barnett, David ^b   Janossy, George ^c   Mandy, Francis ^d   Autran, Brigitte ^e   Rothe, Gregor ^f   Scarpati, Barbara ^a   D'Avanzo, Giovanna ^a   D'Hautcourt, Jean Luc ^g   Lenkei, Rodica ^h   Schmitz, Gerd ^f   Kunkl, Annalisa ⁱ   Chianese, Rosa ^j   Papa, Stefano ^k   Gratama, Jan Willem ^l  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d HEALTH CANADA   (Canada)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^g Hôpital de Warquignies   (Belgium)

^h CALAB Medical Laboratories   (Sweden)

ⁱ UNIVERSITY OF GENOA   (Italy)

^j Legnano Hospital   (Italy)

^k UNIVERSITY OF URBINO   (Italy)

^l ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

Absolute cell count; CD34; CD4; Counting beads; Flow cytometry (FCM); Immunofluorescence (IF); Leukoreduced blood products; Monoclonal antibodies; Single platform

Indexed keywords

CD34 ANTIGEN; CD4 ANTIGEN;

ACCURACY; AUTOANALYZER; BLOOD CELL COUNT; CELL SUBPOPULATION; CYTOFLUOROMETRY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MEASUREMENT; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW;

ANTIGENS, CD34; BLOOD CELL COUNT; CD4 LYMPHOCYTE COUNT; FLOW CYTOMETRY; FORECASTING; HEMOLYSIS; HUMANS; LYMPHOCYTE DEPLETION; MICROSPHERES; MULTICENTER STUDIES; REFERENCE STANDARDS;

EID: 0034671209     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0320(20001215)42:6<327::AID-CYTO1000>3.0.CO;2-F     Document Type: Review

References (191)

1. NIH conference. Acquired immunodeficiency syndrome: Epidemiologic, clinical, immunologic, and therapeutic considerations
2. Evaluation of surrogate markers and clinical outcomes in two-year follow-up of 86 HIV-infected pediatric patients
3. CD4+ T-lymphocyte variations in patients with advanced human immuno-deficiency virus infection and counts below 100 cells per microliter
4. 3
5. Prognostic value of the CD4+ T cell count for HIV-1 infected patients with advanced immunosuppression
6. Predicting outcomes in HW-infected veterans: I. Progression to AIDS. II. Survival after AIDS
7. Longitudinal analysis of CD4 T cell counts, T cell reactivity, and human immunodeficiency virus type I RNA levels in persons remaining AIDS-free despite CD4 cell counts <200 for >5 years
8. Survival after a very low (<5 × 10(6)/1) CD4+ T-cell count in individuals infected with HIV
9. Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals
10. Discontinuation of primary prophylaxis against Pneumocystis carinil pneumonia in HIV-1 infected adults treated with combination antiretroviral therapy
11. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease
12. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection
13. Revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (H1V)
14. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
15. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection
16. Dynamics of fine T-cell subsets during HIV disease and after thymic ablation by mediastinal irradiation
17. Increased numbers of primed activated CD8+CD38+ CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients
18. Increased losses of CD4+CD45RA+ cells in late stages of HIV infection is related to increased risk of death: Evidence from a cohort of 347 HIV-infected individuals
19. Contribution of CD4+, CD8+CD28+, and CD8+CD28- T cells to CD3+ lymphocyte homeostasis during the natural course of HIV-1 infection
20. Quantitation of CD38 activation antigen expression on CD8+ T cells in HIV-1 infection using CD4 expression on CD4+ T lymphocytes as a biological calibrator
21. Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells
22. Immunosuppression by T cell antibodies in renal transplantation
23. Low and very low incidence of acute rejection in kidney grafts treated with initial quadruple therapy: A retrospective analysis comparing two ATGs
24. Administration of ATG according to the absolute T lymphocyte count during therapy for steroid-resistant rejection
25. Peripheral blood lymphoid subsets and long-term clinical course of kidney recipients: A longitudinal study
26. CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients
27. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy
28. Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors
29. Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies
30. Frequent viral infections and delayed CD4+ cell recovery following CD34+ cell-selected autologous peripheral blood stem cell transplantation
31. T cells and natural killer cells after treatment of hairy cell leukemia with 2-chlorodeoxyadenosine
32. Long-lasting decrease of CD4+/CD45RA+ T cells in HCL patients after 2-chlorodeoxyadenosine (2-CdA) treatment
33. Rapid reemergence of T cells into peripheral circulation following treatment of severe and uncomplicated Plasmodium falciparum malaria
34. CD4+ T-cell lymphopenia in Q fever endocarditis
35. T-lymphocyte subsets in early and late phase of cytomegalovirus infection in renal transplant recipients
36. Peripheral blood T and B lymphocyte subpopulations in infants with acute respiratory syncytial virus brochiolitis
37. Postpartum maternal blood helper T (CD3+CD4+) and cytotoxic T (CD3+ CD8+) cells: Correlations with iron status, parity, supplement use, and lactation status
38. T lymphocyte subpopulations in anorexia nervosa and refeeding
39. Lymphocyte subsets in peripheral blood and smoking habits
40. Elevated CD69 expression on naive peripheral blood T-cells in hyperthyroid Graves' disease and autoimmune thyroiditis: Discordant effect of methimazole on HLA-DR and CD69
41. Decreased peripheral blood gamma delta T cells in patients with bronchial asthma
42. The effect of total lymphoid irradiation and low-dose steroids on T lymphocyte populations in multiple sclerosis: Correlation with clinical and MRI status
43. CD8 lymphocyte subsets in active polymyalgia rheumatica: Comparison with elderly-onset and adult rheumatoid arthritis and influence of prednisone therapy
44. Relations between absolute number of CD4+ CD29+ memory cells and levels of interleukin-6, rheumatoid factors, and acute phase proteins in rheumatoid synovial fluid
45. Lymphocyte subsets in patients with ovarian and breast cancer
46. The biology and clinical uses of blood stem cells
47. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells
48. The therapeutic relevance of CD34+ cell dose in blood cell transplantation for cancer therapy
49. Haematopoietic stem cell transplantation for active systemic lupus erythematosus
50. Mobilization and selection of peripheral blood hematopoietic progenitors in children with systemic sclerosis
51. Guideline for the flow cytometric enumeration of CD34+ haematopoietic cells
52. Evaluation of mobilized CD34+ cell counts to guide timing and yield of large-scale collection by leukapheresis
53. Enumeration of CD34+ hematopoietic stem and progenitor cells
54. Peripheral blood CD34+ cell count reliably predicts autograft yield
55. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients
56. Umbilical cord blood collection and separation for haematopoietic progenitor cell banking
57. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype
58. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukemia: First results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation
59. Reduction of intra- and inter-laboratory variation in CD34+ stem cell enumeration by the use of stable test material, standard protocols and targeted training
60. Comparison of single- and dual-platform assay formats for CD34+ haemopoietic progenitor cell enumeration
61. The real CD34+ events: Simplicity versus accuracy and flexibility
62. Effect of fixatives on CD34+ cell enumeration
63. Flow cytometry counting of CD34+ cells in whole blood
64. Leucocyte depletion of cellular blood components
65. Prevention of transfusion-transmitted cytomegalovirus infection
66. Determination of the number of Epstein-Barr virus genomes in whole blood and red cell concentrates
67. Preliminary assessment of whole-blood, red-cell and platelet-leucodepleting filters for possible induction of prion release by leucocyte fragmentation during room temperature processing
68. Prevention of primary HLA class I allo-immunization with leucocyte-poor blood components produced without the use of platelet filters
69. The leukodepletion of cellular blood products in the prevention of HLA-alloimmunization and refractoriness to allogeneic platelet transfusions
70. Systematic use of leukocyte-free blood components to prevent alloimmunization and platelet refractoriness in multitransfused children with cancer
71. Prevention of donor-specific T-cell unresponsiveness after buffy-coat-depleted blood transfusion
72. White cells in freshfrozen plasma: Evaluation of a new white cell-reduction filter
73. Large-volume hemocytometer chamber for accurate counting of white cells (wbcs) in wbc-reduced platelets: Validation and application for quality control of wbc-reduced platelets prepared by apheresis and filtration
74. Validation of a simple method to count very low white cell concentrations in filtered red cells or platelets
75. White cell-reduced red cells prepared by filtration: A critical evaluation of current filters and methods for counting residual white cells
76. 4-Log leukocyte depletion of erythrocyte concentrates. A comparison with 3 other filters
77. Evolution of leukocyte immunophenotyping as influenced by the HIV/AIDS pandemic: A short history of the development of gating strategies for CD4+ T-cell enumeration
78. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry
79. Assessment of the effects of instrumentation, monoclonal antibody, and fluorochrome on flow cytometric immunophenotyping: A report based on 2 years of the NIAID DAIDS flow cytometry quality assessment program
80. Immunologic differentiation of absolute lymphocyte count with an integrated flow cytometric system: A new concept for absolute T cell subset determinations
81. Analyses of quality assessment studies using CD45 for gating lymphocytes for CD3+4+%
82. Consistency of routine measurements of CD4+, CD8+ peripheral blood lymphocytes
83. A parallel evaluation of four automated hematology analyzers
84. Effect of type of haematology analyser on CD4 count
85. A multisite comparison of CD4 and CD8 T lymphocyte counting by single vs multiple platform methodologies: Evaluation of Beckman Coulter Flow-Count fluorospheres and tetra-ONE System
86. Evaluation of TruCount absolute count tubes for determining CD4 and CD8 cell numbers and their comparison to conventional immunophenotyping
87. Absolute CD4+ T-lymphocyte and CD34+ stem cell counts by single-platform flow cytometry: The way forward
88. A comparison of the Coulter STKS, Coulter S + IV, and manual analysis of white blood cell differential counts in a human immunodeficiency virus-infected population
89. Standardization of absolute CD4+ lymphocyte counts across laboratories: An evaluation of the Ortho Cytoron Absolute flow cytometry system on normal donors
90. Proposed reference method for peripheral-blood monocyte counting using fluorescence-labelled monoclonal antibodies
91. Evaluation of the monocyte counting by the ABX Vega. Comparison with the manual method and fluoro-flow cytometry
92. Use of precision profiles to evaluate precision of the automated leukocyte differential
93. Basic principles and problems of haemocytometry
94. A field evaluation of the Coulter STKS
95. Lymphocyte subset determination using a hematology analyzer
96. The Technicon H1. An automated hematology analyzer for today and tomorrow
97. A short evaluation of a new haematological cell counter. The Cell-Dyn 3000, following a modified tentative NCCLS-procedure
98. Sysmex SE-9000 hematology analyzer: Performance evaluation on leukocyte differential counts using an NCCLS H20-A protocol
99. Evaluation of the ABX Cobas Vega automated hematology analyzer and comparison with the Coulter STKS
100. Laboratory evaluation of the Abbott Cell DYN 3500 5-part differential
101. Simultaneous differentiation and quantitation of erythroblasts and white blood cells on a high throughput clinical haematology analyser
102. Quantification of apoptosis by the Abbott CD4000 hematology analyzer
103. Manual and automated methods for the determination of leukocyte counts at extreme low levels: Comparative evaluation of the Nageotte chamber and the Abbott Cell Dyn 3500 analyser
104. Guidelines for the enumeration of CD4 + T lymphocytes in immunosuppressed individuals
105. Enumeration of absolute counts using immunophenotypic techniques
106. Comparison between a lyse-and-then-wash method and a lyse-non-wash technique for the enumeration of CD34+ hematopoietic progenitor cells
107. The influence of different erythrocyte lysing procedures on flow cytometric determination of CD34+ cells in umbilical cord blood transplants
108. Loss of CD34(+) hematopoietic progenitor cells due to washing can be reduced by the use of fixative-free erythrocyte lysing reagents
109. Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood
110. The Q-Prep system: Effects on the apparent expression of leucocyte cell surface antigens
111. Comparative analysis of whole blood lysis methods for flow cytometry
112. Three-color supplement to the NIAID-DAIDS guideline for flow cytometric immunophenotyping
113. Analysis of factors contributing to the formation of mononuclear cell aggregates ("escapees") in flow cytometric immunophenotyping
114. Performance evaluation of the FACSCount system: A dedicated system for clinical cellular analysis
115. Inter- and intrainstitutional evaluation of automated volumetric capillary cytometry for the quantitation of CD4- and CD8-positive T lymphocytes in the peripheral blood of persons infected with human immunodeficiency virus
116. Isotype controls in the analysis of lymphocytes and CD34+ stem/progenitor cells by flow cytometry: Time to let go!
117. The ISHAGE guidelines for CD34+ cell determination by flow cytometry
118. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines
119. Cytofluorimetric analysis of CD34 cells
120. Automated enumeration of CD34+ cells in peripheral blood and bone marrow
121. The "vanishing counting bead phenomenon": Effect on absolute CD34+ cell counting in PBS-diluted luekapheresis
122. Flow-cytometric method for counting very low numbers of leukocytes in platelet products
123. White cell-reduced blood components: Should we go with the flow?
124. Sampling errors and the precision associated with counting very low numbers of white cells in blood components
125. Routine quantitation of white cells as low as 0.001 per μL in platelet components
126. Flow cytometric analysis of residual white blood cell concentration and platelet activation antigens in double filtered platelet concentrates
127. A flow cytometric method for determination of white cell subpopulations in filtered red cells
128. Phenotypic characterization of white cells in white cell-reduced red cell concentrate using flow cytometry
129. Demonstration by flow cytometry of the numbers of residual white blood cells and platelets in filtered red blood cell concentrates and plasma preparations
130. White cell subsets in apheresis and filtered platelet concentrates
131. Flow cytometric determination of residual leucocytes in filter-depleted blood products: An evaluation of Becton-Dickinson's Leuco-COUNT system
132. Evaluation of IMAGN 2000: A new system for absolute leucocyte count
133. Enumeration of CD4+ T-cells in the peripheral blood of HIV-infected patients: An interlaboratory study of the FACSCount system
134. Automatic volumetric capillary, cytometry for counting white cells in white cell-reduced plateletpheresis components
135. Volumetric capillary cytometry: A new method for absolute cell enumeration
136. Enumeration of CD34-positive stem cells: Evaluation and comparison of three methods
137. Comparison of volumetric capillary cytometry with standard flow cytometry for routine enumeration of CD34+ cells
138. Toward standardization of CD34+ cell enumeration: An international study
139. Quantitation of cell concentration using the flow cytometer
140. A new method for fast blood cell counting and partial differentiation by flow cytometry
141. Evaluation of a flow cytometric method for simultaneous leukocyte phenotyping and quantification by fluorescent microspheres
142. Determination of T-lymphocyte subsets on site in rural Tanzania: Results in HIV-1 infected and non-infected individuals
143. Evaluation of four alternative methodologies for determination of absolute CD4+ lymphocyte counts. The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study
144. Evaluation of the FACScount, TRAx CD4 and Dynabeads methods for CD4 lymphocyte determination
145. Evaluation of a method for counting absolute numbers of cells with a flow cytometer
146. Intérét de la numération absolue per citométrie en flux et du quadruple marquage des sous-populations lymphocytaires lors de l' infection par le VIH
147. Determination of hematopoietic stem cells in peripheral blood by an automated hematology analyzer (SE-9000)
148. Determination of CD4+ and CD8+ lymphocytes with the cytosphere assay: A comparative study with flow cytometry and the immunoalkaline phosphatase method
149. A manual bead assay for the determination of absolute CD4+ and CD8+ lymphocyte counts in human immunodeficiency virus-infected individuals
150. Evaluation of alternative CD4 technologies for the enumeration of CD4 lymphocytes
151. CD4 lymphocyte enumeration: Comparison between flow cytometry and enzyme immunoassay
152. Comparison of CD4 cell count by a simple enzyme-linked immunosorbent assay using the TRAx CD4 test kit and by flow cytometry and hematology
153. Comparison of absolute CD4+ lymphocyte counts determined by enzyme immunoassay (TRAx CD4 test kit) and flow cytometry
154. Determination of CD4 and CD8 lymphocyte subsets by a new alternative fluorescence immunoassay
155. Two-site enzyme immunoassay of CD4 and CD8 molecules on the surface of T lymphocytes from healthy subjects and HIV-1-infected patients
156. Whole blood Capcellia CD4/CD8 immunoassay for enumeration of CD4+ and CD8+ peripheral T lymphocytes
157. Statistical methods for assessing agreement between two methods of clinical measurement
158. Analysis of method comparison studies
159. CD4+ T cell enumeration in HIV infection with limited resources
160. Affordable CD4+ T cell counts on "single-platform" flow cytometers. I. Primary. CD4 gating
161. CD4+ T cell absolute count. A crossed comparison among three flow cytometric methods and plate ELISA test in 325 HIV+ patients
162. Use of the LMAGN2000 single-platform method for the quantitative evaluation of T CD4+ peripheral blood lymphocytes
163. Development of a "minimal technology" procedure for absolute counting of CD4 + cells in HIV+ patients
164. Evaluation of a novel stable whole blood quality control material for lymphocyte subset analysis: Results from the UK NEQAS immune monitoring scheme
165. + cell estimations in peripheral blood for autografting in patients with cancer
166. The influence of flow cytometric gating strategy on the standardization of CD34+ cell quantitation: An Australian multicenter study
167. North American multicenter study on flow cytometric enumeration of CD34+ hematopoietic stem cells
168. Analysis of variation in results of CD34+ hematopoietic progenitor cell enumeration in a multicenter study
169. Quality assurance of stem cell enumeration by flow cytometry
170. Quality assessment of CD34+ stem cell enumeration: Experience of the United Kingdom National External Quality Assessment Scheme (UK NEQAS) using a unique stable whole blood preparation
171. Validation of the Nordic flow cytometry standard for CD34+ cell enumeration in blood and autografts: Report from the third workshop
172. Enumeration of CD34-positive hematopoietic progenitor cells by flow cytometry: Comparison of a volumetric assay and the ISHAGE gating strategy
173. Minimization of CD34+ cell enumeration variability using the Pro-COUNT standardized methodology
174. CD34+ cell enumeration in peripheral blood and apheresis samples, using two laboratory diagnostic kits or an institutional protocol
175. Measurement error of absolute CD4+ T lymphocyte count double platform evaluations for the assessment of laboratory performance in lymphocyte immunophenotyping quality control
176. Effect of CD4+ cell count measurement variability on staging HIV-1 infection
177. Circannual variation in lymphocyte subsets, revisited
178. Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: Implications for patient monitoring
179. Quantification of the variation due to laboratory and physiologic sources in CD4 lymphocyte counts of clinically stable HIV-infected individuals
180. Diurnal change of blood count analytes in normal subjects
181. Impact of unified procedures as implemented in the Canadian quality assurance program for T lymphocyte subset enumeration
182. Absolute number of circulating CD34+ cells is abnormally low in refractory anemias and extremely high in RAEB and RAEB-t. Novel pathologic features of myelodysplastic syndromes identified by highly sensitive flow cytometry
183. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation
184. Automation of human sperm cell analysis by flow cytometry
185. HLA-peptide tetrameric complexes
186. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART)